Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A brain-wide map of descending inputs onto spinal V1 interneurons.
Chapman PD, Kulkarni AS, Trevisan AJ, Han K, Hinton JM, Deltuvaite P, Fenno LE, Ramakrishnan C, Patton MH, Schwarz LA, Zakharenko SS, Deisseroth K, Bikoff JB. Chapman PD, et al. Among authors: kulkarni as. Neuron. 2024 Dec 19:S0896-6273(24)00876-6. doi: 10.1016/j.neuron.2024.11.019. Online ahead of print. Neuron. 2024. PMID: 39719703 Free article.
Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic Cancer.
Dimitrieva S, Harrison JM, Chang J, Piquet M, Mino-Kenudson M, Gabriel M, Sagar V, Horn H, Lage K, Kim J, Li G, Weng S, Harris C, Kulkarni AS, Ting DT, Qadan M, Fagenholz PJ, Ferrone CR, Grauel AL, Laszewski T, Raza A, Riester M, Somerville T, Wagner JP, Dranoff G, Engelman JA, Kauffmann A, Leary R, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C, Ruddy DA, Liss AS, Cremasco V. Dimitrieva S, et al. Among authors: kulkarni as. Cancer Res Commun. 2024 Dec 1;4(12):3049-3066. doi: 10.1158/2767-9764.CRC-23-0489. Cancer Res Commun. 2024. PMID: 39485038 Free PMC article.
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.
Park RJ, Parikh M, Pappas L, Sade-Feldman M, Kulkarni AS, Bi L, LaSalle TJ, Galway A, Kuhlman C, Blaszkowsky LS, Meyerhardt JA, Enzinger PC, Biller L, Allen JN, Kagey MH, Baum J, Sirard C, Duda DG, Zhu AX, Abrams TA, Hacohen N, Ting DT, Mehta A, Goyal L. Park RJ, et al. Among authors: kulkarni as. medRxiv [Preprint]. 2024 Oct 8:2024.10.08.24315092. doi: 10.1101/2024.10.08.24315092. medRxiv. 2024. PMID: 39417106 Free PMC article. Preprint.
141 results